The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer

International Journal of Cancer

Volumn 105, Issue 4, 2003, Pages 472-479

  Hansen, Lasse Tengbjerg ^a   Lundin, Cecilia ^b   Spang Thomsen, Mogens ^a   Petersen, Lone Nørgård ^a   Helleday, Thomas ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

DNA double strand break repair; Homologous recombination; RAD51, etoposide; Small cell lung cancer

Indexed keywords

ETOPOSIDE; RAD51 PROTEIN;

ARTICLE; CELL CYCLE G2 PHASE; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG EFFECT; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC RECOMBINATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TARGET CELL;

CARCINOMA, SMALL CELL; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RAD51 RECOMBINASE; TUMOR CELLS, CULTURED;

EID: 0037986421     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11106     Document Type: Article

References (43)

1. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
2. Leith JT, Dexter DL, DeWyngaert JK, Zeman EM, Chu MY, Calabresi P, Glicksman AS. Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. Cancer Res 1982;42:2556-61.
3. Trope C, Hakansson L, Dencker H. Heterogeneity of human adenocarcinomas of the colon and the stomach as regards sensitivity to cytostatic drugs. Neoplasma 1975;22:423-9.
4. Hansen HH. Management of small-cell cancer of the lung. Lancet 1992;339:846-9.
5. Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients. J Clin Oncol 1995;13:1215-20.
6. Robert J, Larsen AK. Drug resistance to topoisomerase II inhibitors. Biochimie 1998;80:247-54.
7. Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M. Double-strand breaks and tumorigenesis. Trends Cell Biol 2001;11: S52-9.
8. Binaschi M, Capranico G, De Isabella P, Mariani M, Supino R, Tinelli S, Zunino F. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors. Int J Cancer 1990;45:347-52.
9. van Gent DC, Hoeijmakers JH, Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2001;2:196-206.
10. Flygare J, Benson F, Hellgren D. Expression of the human RAD51 gene during the cell cycle in primary human peripheral blood lymphocytes. Biochim Biophys Acta 1996;1312:231-6.
11. Haaf T, Golub EI, Reddy G, Radding CM, Ward DC. Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci USA 1995;92:2298-302.
12. Haaf T, Raderschall E, Reddy G, Ward DC, Radding CM, Golub EI. Sequestration of mammalian Rad51-recombination protein into micronuclei. J Cell Biol 1999;144:11-20.
13. Liu Y and Maizels N. Coordinated response of mammalian Rad51 and Rad52 to DNA damage. EMBO Rep 2000;1:85-90.
14. Vispe S, Cazaux C, Lesca C, Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 1998; 26:2859-64.
15. Arnaudeau C, Helleday T, Jenssen D. The RAD51 protein supports homologous recombination by an exchange mechanism in mammalian cells. J Mol Biol 1999;289:1231-8.
16. Yanez RJ, Porter AC. Gene targeting is enhanced in human cells overexpressing hRAD51. Gene Ther 1999;6:1282-90.
17. Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R, Skorski T. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001;8:795-806.
18. Thacker J, Tambini CE, Simpson PJ, Tsui LC, Scherer SW. Localization to chromosome 7q36.1 of the human XRCC2 gene, determining sensitivity to DNA-damaging agents. Hum Mol Genet 1995;4:113-20.
19. Johnson MA, Jones NJ. The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants. Mutat Res 1999;435:271-82.
20. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 1999;13:2633-8.
21. Jeggo PA, Caldecott K, Pidsley S, Banks GR. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res 1989;49:7057-63.
22. Yuan ZM, Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kharbanda S, Wang R, Sung P, Shinohara A, Weichselbaum R, Kufe D. Regulation of Rad51 function by c-Abl in response to DNA damage. J Biol Chem 1998;273:3799-802.
23. Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff SP, Wu Y, Arlinghaus R, Baltimore D, Gasser PJ, et al.. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem 1999;274:12748-52.
24. Flygare J, Armstrong RC, Wennborg A, Orsan S, Hellgren D. Proteolytic cleavage of HsRad51 during apoptosis. FEBS Lett 1998;427:247-51.
25. Huang Y, Nakada S, Ishiko T, Utsugisawa T, Datta R, Kharbanda S, Yoshida K, Talanian RV, Weichselbaum R, Kufe D, Yuan ZM. Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage. Mol Cell Biol 1999;19:2986-97.
26. Jackson SP. DNA-dependent protein kinase. Int J Biochem Cell Biol 1997;29:935-8.
27. Lee SE, Mitchell RA, Cheng A, Hendrickson EA. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol 1997;17:1425-33.
28. Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS, III, Barron GM, Allalunis-Turner J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 1995;267:1183-5.
29. CS components of the DNA-dependent protein kinase. Carcinogenesis 1998;19:965-71.
30. Meng H, Terado T, Kimura H. Apoptosis induced by X-rays and chemical agents in murine fibroblastic cell lines with a defect in repair of DNA double-strand breaks. Int J Radiat Biol 1998;73:503-10.
31. Sirzen F, Nilsson A, Zhivotovsky B, Lewensohn R. DNA-dependent protein kinase content and activity in lung carcinoma cell lines: correlation with intrinsic radiosensitivity. Eur J Cancer 1999;35:111-6.
32. Vaganay-Juery S, Muller C, Marangoni E, Abdulkarim B, Deutsch E, Lambin P, Calsou P, Eschwege F, Salles B, Joiner M, Bourhis J. Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. Br J Cancer 2000;83:514-8.
33. Krarup M, Poulsen HS, Spang-Thomsen M. Cellular radiosensitivity of small-cell lung cancer cell lines. Int J Radiat Oncol Biol Phys 1997;38:191-6.
34. Pedersen MW, Holm S, Lund EL, Hojgaard L, Kristjansen PE. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 2001;3:80-7.
35. Lundin C, Samuelsson M, Helleday T. Overexpression of cyclin E does not influence homologous recombination in Chinese hamster cells. Biochem Biophys Res Commun 2002;296:363.
36. Basnakian AG and James SJ. A rapid and sensitive assay for the detection of DNA fragmentation during early phases of apoptosis. Nucleic Acids Res 1994;22:2714-5.
37. Arnaudeau C, Lundin C, Helleday T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001;307:1235-45.
38. Wang ZM, Chen ZP, Xu ZY, Christodoulopoulos G, Bello V, Mohr G, Aloyz R, Panasci LC. In vitro evidence for homologous recombinational repair in resistance to melphalan. J Natl Cancer Inst 2001; 93:1473-8.
39. Boulton S, Kyle S, Durkacz BW. Mechanisms of enhancement of cytotoxicity in etoposide and ionising radiation-treated cells by the protein kinase inhibitor wortmannin. Eur J Cancer 2000;36:535-41.
40. Eriksson A, Lewensoh R, Larsson R, Nilsson A. DNA-dependent protein kinase in leukaemia cells and correlation with drug sensitivity. Anticancer Res 2002;22:1787-93.
41. Rygaard K, Vindelov LL, Spang-Thomsen M. Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts. Int J Cancer 1993;54:144-52.
42. Catapano CV, Carbone GM, Pisani F, Qiu J, Fernandes DJ. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26. Biochemistry 1997;36:5739-48.
43. Hendrickson EA. Cell-cycle regulation of mammalian DNA double-strand-break repair. Am J Hum Genet 1997;61:795-800.